Literature DB >> 7637016

Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4.

L A Samaniego1, A L Webb, N A DeLuca.   

Abstract

Two of the five immediate-early gene products, ICP4 and ICP27, expressed by herpes simplex virus type 1 have profound effects on viral gene expression and are absolutely essential for virus replication. Functional interactions between ICP4 and ICP27 may contribute to establishing the program of viral gene expression that ensues during lytic infection. To evaluate this possibility, viral mutants simultaneously deleted for ICP27 and defined functional domains of ICP4 were constructed. These mutant viruses allowed a comparison of gene expression as a function of different domains of ICP4 in the presence and absence of ICP27. Gene expression in the absence of both ICP4 and ICP27 was also examined. The results of this study demonstrate a clear involvement for ICP27 in the induction of early genes, in addition to its known role in enhancing late gene expression during viral infection. In the absence of both ICP4 and ICP27, viral early gene expression, as measured by the accumulation of thymidine kinase and ICP6 messages was dramatically reduced relative to the amounts of these messages seen in the absence of only ICP4. Therefore, elevated levels of early gene expression as a consequence of ICP27 occurred in the absence of any ICP4 activity. Evidence is also presented regarding the modulation of the ICP4 repression function by ICP27. When synthesized in the absence of ICP27, a mutant ICP4 protein was impaired in its ability to repress transcription from the L/ST promoter in the context of viral infection and in vitro. This defect correlated with the loss of the ability of this mutant protein to bind to its recognition sequence when produced in infected cells in the absence of ICP27. These observations indicate that ICP27 can regulate the activity of at least one domain of the ICP4 protein as well as contribute to elevated early gene expression independently of ICP4.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637016      PMCID: PMC189430     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Direct correlation between a negative autoregulatory response element at the cap site of the herpes simplex virus type 1 IE175 (alpha 4) promoter and a specific binding site for the IE175 (ICP4) protein.

Authors:  M S Roberts; A Boundy; P O'Hare; M C Pizzorno; D M Ciufo; G S Hayward
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

2.  Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4.

Authors:  N A DeLuca; P A Schaffer
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.

Authors:  D J Goldstein; S K Weller
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.

Authors:  W R Sacks; P A Schaffer
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Binding of the herpes simplex virus immediate-early gene product ICP4 to its own transcription start site.

Authors:  M T Muller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

6.  The DNA-binding properties of the major regulatory protein alpha 4 of herpes simplex viruses.

Authors:  N Michael; D Spector; P Mavromara-Nazos; T M Kristie; B Roizman
Journal:  Science       Date:  1988-03-25       Impact factor: 47.728

7.  Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides.

Authors:  N A DeLuca; P A Schaffer
Journal:  Nucleic Acids Res       Date:  1987-06-11       Impact factor: 16.971

8.  Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110.

Authors:  N D Stow; E C Stow
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

9.  Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27.

Authors:  S A Rice; D M Knipe
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

10.  Mutational dissection of the HSV-1 immediate-early protein Vmw175 involved in transcriptional transactivation and repression.

Authors:  T Paterson; R D Everett
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

View more
  57 in total

1.  Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.

Authors:  C E Lilley; F Groutsi; Z Han; J A Palmer; P N Anderson; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

Authors:  W E Hobbs; D E Brough; I Kovesdi; N A DeLuca
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Identification of a motif in the C terminus of herpes simplex virus regulatory protein ICP4 that contributes to activation of transcription.

Authors:  James W Bruce; Kent W Wilcox
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection.

Authors:  Kasey M Eidson; William E Hobbs; Brian J Manning; Paul Carlson; Neal A DeLuca
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 6.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

7.  The N terminus and C terminus of herpes simplex virus 1 ICP4 cooperate to activate viral gene expression.

Authors:  Lauren M Wagner; Jonathan T Lester; Frances L Sivrich; Neal A DeLuca
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

8.  DNA mismatch repair proteins are required for efficient herpes simplex virus 1 replication.

Authors:  Kareem N Mohni; Adam S Mastrocola; Ping Bai; Sandra K Weller; Christopher D Heinen
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

9.  Mutational analysis of the herpes simplex virus type 1 ICP0 C3HC4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential alpha27 gene.

Authors:  E K Lium; S Silverstein
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

10.  Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.

Authors:  R Kato; D Wolfe; C H Coyle; J B Wechuck; P Tyagi; T Tsukamoto; J B Nelson; J C Glorioso; M B Chancellor; N Yoshimura
Journal:  Gene Ther       Date:  2008-07-31       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.